Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

Presentation

Long-term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries

December 02, 2019

Presentation Controversies and Advances 2019

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention

Presenter: Tarun Chakravarty

November 15, 2019

Presentation SIF 2019

Left Atrial Appendage Closure is an Under-Utilized Therapy

Presenter: Brij Maini

March 27, 2019

Presentation JIM 2018

Left atrial appendage Closure Overview & Case Examples

Presenter: Mark Spence

February 22, 2018

Presentation LAA 2017

LAA and PFO Closure - Interventional Prevention of Cardioembolic Stroke: A Technique-Oriented Course

Presenter: Apostolos Tzikas

July 22, 2017

Presentation LAA 2017

LAA Closure: Shared Decision Making Criteria and Documentation

Presenter: Megan Coylewright

July 21, 2017

Presentation LAA 2017

Left Atrial Appendage Occlusion as Adjunctive Therapy

Presenter: Amar Krishnaswamy

July 21, 2017

Presentation LAA 2017

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Presenter: Vivek Y. Reddy

July 21, 2017

Presentation EuroPCR 2016

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

May 20, 2016

Presentation ECHO 2016

Clinical Decision Making: Stroke and Structural Interventions

Presenter: Robert J. Sommer

March 23, 2016

Presentation JIM 2016

The Italian Experience with the Amplatzer Technology

Presenter: Jacopo A Oreglia

February 10, 2016

Presentation Scripps 2016

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

Presenter: Brian Whisenant

February 04, 2016

Presentation Scripps 2016

LAA Closure for Stroke Prevention: Rationale and Identifying the Patient Who Might Benefit

Presenter: Brian K. Whisenant

February 03, 2016

Presentation Scripps 2016

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

Presenter: Brian K. Whisenant

February 03, 2016

Presentation

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Presenter: Vivek Y. Reddy

December 13, 2015

Presentation

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Presenter: David R. Holmes Jr

June 16, 2015

Presentation

LAA Occlusion for Stroke Prevention in A-Fib

Presenter: Apostolos Tzikas

January 29, 2015

Presentation

Utilization and Adverse Outcomes of Percutaneous LAA Closure for Stroke Prevention in A-fib in the US

Presenter: AO Badheka

December 11, 2014

Presentation TCT 2014

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

Presenter: Vivian Lee

September 16, 2014

Presentation TCT 2014

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Presenter: George Hanzel

September 16, 2014

Advertisement

Long-term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention

Left Atrial Appendage Closure is an Under-Utilized Therapy

Left atrial appendage Closure Overview & Case Examples

LAA and PFO Closure - Interventional Prevention of Cardioembolic Stroke: A Technique-Oriented Course

LAA Closure: Shared Decision Making Criteria and Documentation

Left Atrial Appendage Occlusion as Adjunctive Therapy

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Clinical Decision Making: Stroke and Structural Interventions

The Italian Experience with the Amplatzer Technology

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

LAA Closure for Stroke Prevention: Rationale and Identifying the Patient Who Might Benefit

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

LAA Occlusion for Stroke Prevention in A-Fib

Utilization and Adverse Outcomes of Percutaneous LAA Closure for Stroke Prevention in A-fib in the US

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content